Troglitazone
Troglitazone
Supplier: Abcam
Potent, selective PPAR-γ receptor agonist (EC₅₀ = 780 nM). No activity at PPAR-α or PPAR-δ (up to 10 mM). Orally active. Antidiabetic and anticancer agent. Active in vivo and in vitro.
Expand 2 Items
Troglitazone >98% PPARg agonist
Supplier: G-Biosciences
PPARgamma agonist. Stimulates recruitment of transcriptional coactivators to PPARgamma at 1 µM. Stimulates adipogenesis in human mesenchymal stem cells. Induces apoptosis in a variety of tumor cells lines. Cell permeable.
Expand 2 Items
Troglitazone ≥98%
Supplier: Adipogen
Potent and selective PPARgamma agonist with no activation of PPARalpha and PPARdelta. Anti-diabetic agent with potent glucose-lowering effects and decreasing insulin resistance in adipose tissues. Stimulates adipogenesis. Apoptosis and cell cycle arrest inducer in several cancer cell lines. Anti-inflammatory. Inhibits vascular smooth muscle cell (VSMC) migration.



